Vessela N. Kristensen

Genetic variants of CYP19 (aromatase) and breast cancer risk

Vessela N. Kristensen, Nobuhiro Harada, Noriko Yoshimura et al. · Oncogene · 2000 · 166 citations

Breast Oncology, Breast Cancer Risk, Cancer Risk +6

High-Throughput Methods for Detection of Genetic Variation

Vessela N. Kristensen, Dimitris Kelefiotis, Tom Kristensen et al. · BioTechniques · 2001 · 161 citations · Full text

Genetics, Genetic Epidemiology, Human Polymorphism +18

CYP17 and breast cancer risk: the polymorphism in the 5' flanking area of the gene does not influence binding to Sp-1.

Vessela N. Kristensen, Ellen K. Haraldsen, Kristin B. Anderson et al. · PubMed · 1999 · 152 citations

Breast Oncology, Genetics, Pathology +17

A rare CYP19 (aromatase) variant may increase the risk of breast cancer

Vessela N. Kristensen, Tone Ikdahl Andersen, Annika Lindblom et al. · Pharmacogenetics · 1998 · 119 citations

Common Breast Cancer Susceptibility Variants in <i>LSP1</i> and <i>RAD51L1</i> Are Associated with Mammographic Density Measures that Predict Breast Cancer Risk

Celine M. Vachon, Christopher G. Scott, Peter A. Fasching et al. · Cancer Epidemiology Biomarkers & Prevention · 2012 · 108 citations · Full text